EPISODE · Aug 29, 2023 · 16 MIN
What Medicare Drug Price Negotiations Mean for Diabetes
from Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives · host Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
In this special edition episode, hosts break down what the announcement of the 10 drugs selected for Medicare price negotiations under the Inflation Reduction Act means for providers and people with diabetes. The 4 diabetes agents included on the list, which were empagliflozin, dapagliflozin, sitagliptin, and Novo Nordisk-branded insulin products, accounted for more than $16 billion in Part D spending in 2022.
NOW PLAYING
What Medicare Drug Price Negotiations Mean for Diabetes
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m